Chris Cavallini and Jay Campbell discuss the implications of peptides and GLP-1 drugs on men's health and the influence of Big Pharma.
On this hard-hitting episode of Start Today , I bring back Jay Campbell to expose what's really happening behind the scenes with peptides, GLP-1 drugs, and Big Pharma's quiet push to shut down affordable optimization. We break down why January could change everything —from access restrictions to rising costs—and what men need to know now before the window closes. We also get into why Ozempic is already obsolete, what's coming next with GLP-3s, how peptides actually work, and the three non-negotiables for men who want strength, clarity, and longevity. No hype. No shortcuts. Just real talk you won't hear from your doctor. 🔥Top Highlights: 0:42 Injecting the strongest nootropic on air 06:12 Big Pharma vs peptides: what's coming in January 2026 19:10 GLP-3 (Retatrutide) vs Ozempic: why semaglutide is obsolete 34:47 The study: 71 pounds lost on 12mg/week with zero exercise 39:08 The non-negotiables before using any GLP 46:33 Creatine for brain health (not just muscle) 1:01:55 Fear-free testosterone injections (MCT oil) 1:13:07 SLU-PP-332 — "exercise in a bottle?" 🔗 Resources Follow Jay on Instagram: https://www.instagram.com/jaycampbell333/ Website: https://jaycampbell.com/ Bio…
Host: Chris Cavallini
Guest: Jay Campbell
Organizations: Big Pharma
Products: Ozempic, GLP-1, GLP-3, Retatrutide
Books & works: Metabolic Awakening with GLP-1 Peptides
Explore listener stats, chart rankings, contacts and more on the Start Today Podcast podcast page.